SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-029599
Filing Date
2021-11-22
Accepted
2021-11-22 17:00:52
Documents
75
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1883122
2 ex31-1.htm EX-31.1 19451
3 ex31-2.htm EX-31.2 19870
4 ex32-1.htm EX-32.1 6384
5 ex32-2.htm EX-32.2 6540
  Complete submission text file 0001493152-21-029599.txt   9599305

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE otlc-20210930.xsd EX-101.SCH 68882
7 XBRL CALCULATION FILE otlc-20210930_cal.xml EX-101.CAL 57978
8 XBRL DEFINITION FILE otlc-20210930_def.xml EX-101.DEF 382097
9 XBRL LABEL FILE otlc-20210930_lab.xml EX-101.LAB 533506
10 XBRL PRESENTATION FILE otlc-20210930_pre.xml EX-101.PRE 476977
11 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1524237
Mailing Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301
Business Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301 650-635-7000
Oncotelic Therapeutics, Inc. (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21990 | Film No.: 211433335
SIC: 2834 Pharmaceutical Preparations